Search Results for "Treatment Of Neurofibroma In India"

11:56 EDT 30th August 2015 | BioPortfolio

Matching Channels


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to:    

Hormonal treatment

Immunomodulating treatment

Matching News

Mylan Launches Sovaldi Tablets in India

​Mylan N.V. announced that its subsidiary, Mylan Pharmaceuticals Private Ltd, has launched Gilead Sciences' Sovaldi (sofosbuvir 400mg tablets) in India. Sovaldi is indicated for the treatment of chr...

India Network Foundation Assists NGOs Serving Millions of Godavari Pushkaram Kumbhmela Pilgrims in Rajahmundry, Siddantham, and Narasapuram, Andhra Pradesh, India

Orlando, FL (PRWEB) July 19, 2015 India Network Foundation , a non profit organization in the US, sponsors various programs for the...

Leader Biomedical Group Commences Operations in India

HONG KONG and AMSTERDAM: Leader Biomedical Group has increased its global footprint by establishing an entity in Bangalore, India: Leader Biomedical and Surgicals India Pvt. Ltd ("Leader Bio...

BRIEF-IBA and Philips to introduce proton therapy in India

* To introduce proton therapy cancer treatment in India together with Philips India through exclusive alliance

Hetero Received Generic Sofosbuvir (Gilead's Sovaldi) Approval From Drug Controller General of India (DCGI)

HYDERABAD, INDIA -- (Marketwired) -- 03/12/15 -- Hetero, a leading pharmaceutical company based in Hyderabad, India, today announced that it has received approval for generic Sofosbuvir Tablets, 400...

'Responsibly' priced Invokana debuts in India

The daily cost of therapy with Invokana in India is INR51 ($0.8), generally comparable with the newer treatment options available in the country and a fraction of the product's US cost, reported in so...

Canada, India fund 5 innovations to improve health in India, with focus on mothers and children

(Terry Collins Assoc) Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship...

BioAsia 2015: Fixes To India’s Medicines Access Issue

Access to medicines is a hot button topic in India. The government has spoken on interventions like establishing low cost generic drug stores, while the industry is toying with financing models to imp...

Matching PubMed Articles

TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?

In India, the Revised National TB Control Programme (RNTCP) envisages initiation of TB treatment within seven days of diagnosis among smear-positive patients. After nearly two decades of RNTCP impleme...

Solitary Epibulbar Neurofibroma in Older Adult Patients.

To report a solitary epibulbar neurofibroma in 2 elderly patients without systemic neurofibromatosis.

Ketotifen suppression of NF1 neurofibroma growth over 30 years.

A patient with NF1 was treated with oral ketotifen for 30 years since infancy. Review of the patient's course and treatment details establishes a basis for reconsideration of several fundamental prece...

An Observational Study on the Use of IV Iron Sucrose Among Anaemic Pregnant Women in Government Healthcare Facilities from Two States of India.

In India oral iron tablets for anaemia have been distributed through the health system since many years, but there has been no significant change in the burden of anaemia. The objective of the present...

An unusual cause of hemoperitoneum: case report with review of literature.

Spontaneous hemoperitoneum (SH) is a rare entity which can be life-threatening. Gastrointestinal neurofibromas are rare. Occasionally, such lesions may be the initial sign of NF1 in patients without a...

Search Whole site using Google


Advertisement Advertisement